LASIK治疗远视:美国眼科学会报告
本报告系统评估LASIK治疗远视的有效性、可预测性、安全性和稳定性。检索PubMed数据库(末次检索2025年8月),最终纳入20项研究(共25个队列),证据等级为I级2项、II级6项、III级12项。结论认为,使用当前准分子激光机型(脉率更快、光学区更大、切削模式更新)行远视LASIK,上述四项指标均相对较高。
要点
- 18个有效性队列中,至少80%眼达成UCDVA 20/40或更好。
- 19个可预测性队列中16个超过60%眼在±0.50 D内,21个队列中16个超过90%眼在±1.00 D内。
- 稳定性较差与远视矫正度数更高、脉率<500 Hz、激光机型较旧及光学区≤6 mm相关。
核心结论
- 使用当前准分子激光机型行远视LASIK,似具有相对较高的有效性、可预测性、安全性和稳定性。
研究设计与样本
- 美国眼科学会报告,基于PubMed文献检索(末次检索2025年8月),初检198篇,88篇全文复评,最终纳入20项研究共25个队列,并由方法学家评定证据等级。
主要发现
- 证据等级为I级2项、II级6项、III级12项。
- 18个有效性队列中至少80%眼UCDVA达20/40或更好,其中16个队列至少50%眼达20/20或更好。
- 19个可预测性队列中16个超过60%眼在±0.50 D内;21个队列中16个超过90%眼在±1.00 D内,所有队列至少80%眼在该范围内。
- 23个安全性队列中19个CDVA下降2行或以上的眼不超过3%,15个不超过1%;安全指数为0.97至1.05。
- 3至6个月屈光稳定性分析中,平均等效球镜变化为0.05 D(最大0.3 D)。
关键数值与推荐
- 有效性:至少80%眼UCDVA 20/40或更好;16/18队列至少50%眼UCDVA 20/20或更好。
- 可预测性:16/19队列超过60%眼在±0.50 D内;16/21队列超过90%眼在±1.00 D内,所有队列至少80%眼在±1.00 D内。
- 安全性:19/23队列CDVA下降2行或以上眼不超过3%,15/23队列不超过1%;安全指数0.97至1.05。
- 稳定性:3至6个月平均等效球镜变化0.05 D,最大0.3 D;较差稳定性与更高远视矫正、脉率<500 Hz、较旧激光机型及光学区≤6 mm相关。
临床怎么用
- 远视LASIK术前可参考本报告的有效性、可预测性、安全性和稳定性数据评估预期。
- 选择脉率更快、光学区更大及切削模式更新的准分子激光机型,可能有利于稳定性。
- 对较高远视矫正、光学区≤6 mm或使用较旧机型者,应更关注屈光稳定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the effectiveness, predictability, safety, and stability of LASIK for hyperopia. METHODS: A literature search of the PubMed database was last conducted in August 2025. The search yielded 198 articles that were reviewed in abstract form, 88 of which were selected for full-text review. Twenty studies (containing a total of 25 different cohorts) met the criteria for inclusion in this assessment. The panel methodologists assigned a level of evidence rating to each study. RESULTS: Two studies were rated level I, 6 studies were rated level II, and 12 studies were rated level III. Of the 18 cohorts for which effectiveness data were presented, at least 80% of eyes achieved an uncorrected distance visual acuity (UCDVA) of 20/40 or better, and in 16 of 18 cohorts, at least 50% of eyes achieved a UCDVA of 20/20 or better. Among the cohorts reporting predictability outcomes, 16 of 19 achieved more than 60% of eyes within ±0.50 diopter (D) of the intended correction. Likewise, 16 of 21 cohorts reported more than 90% of eyes within ±1.00 D of target, and all cohorts reached at least 80% within this range. Of the 23 cohorts for which safety data were presented, 19 cohorts contained no more than 3% and 15 cohorts contained no more than 1% of eyes losing 2 lines or more of Snellen corrected distance visual acuity (CDVA). The safety index (ratio of postoperative CDVA to preoperative CDVA) ranged from 0.97 to 1.05. In the cohorts in which refractive stability between 3 and 6 months was analyzed, the average spherical equivalent variation was 0.05 D (maximum, 0.3 D). Worse stability outcomes were associated with higher hyperopia treatments, slower pulse rates (< 500 Hz), older laser models, and smaller optical zones (≤ 6 mm). CONCLUSIONS: LASIK for hyperopia performed using the current excimer laser models (characterized by faster pulse rates, larger optical zones, and updated ablation profiles) seems to have relatively high rates of effectiveness, predictability, safety, and stability. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references in the Footnotes and Disclosures at the end of this article.
引用
- Santhiago MR, Steigleman WA, Al-Mohtaseb ZN, et al. LASIK for Hyperopia: A Report by the American Academy of Ophthalmology. Ophthalmology. 2026. PMID: 41569212. doi:10.1016/j.ophtha.2025.11.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。